Awakn Life Sciences Corp. reported earnings results for the second quarter and six months ended July 31, 2023. For the second quarter, the company reported revenue was CAD 0.024622 million. Net loss was CAD 1.75 million compared to CAD 2.39 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.06 a year ago.
For the six months, revenue was CAD 0.036615 million. Net loss was CAD 3.43 million compared to CAD 5.19 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.13 a year ago.